Welcome to our dedicated page for Neuberger High Yield Strategies news (Ticker: NHS), a resource for investors and traders seeking the latest updates and insights on Neuberger High Yield Strategies stock.
Neuberger High Yield Strategies Fund Inc. reports fund developments for a closed-end management investment company focused on high total return through income and capital appreciation. Under normal market conditions, the Fund invests at least 80% of total assets in below-investment-grade debt securities of U.S. and foreign issuers, with capacity for other securities, financial instruments and collateralized loan obligations.
Recurring news for NHS centers on monthly common-stock distributions under its level distribution policy, the income and expense factors that affect those distributions, and capital actions such as transferable rights offerings. Updates also reference NAV-based pricing mechanics, leverage costs, fund fees and the role of Neuberger Berman Investment Advisers LLC as investment adviser.
Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) has declared a distribution of $0.0905 per share, payable on December 30, 2022. The record date is December 15, 2022, with an ex-date of December 14, 2022. The Fund aims for regular monthly distributions of the same amount, contingent on market conditions and investment income stability. Distributions may include net investment income, capital gains, and return of capital. Neuberger Berman manages $408 billion in client assets as of September 30, 2022, and emphasizes its ESG commitment.
Neuberger Berman High Yield Strategies Fund (NYSE American: NHS) has declared a monthly distribution of $0.0905 per share, payable on November 30, 2022, with a record date of November 15, 2022 and an ex-date of November 14, 2022. The fund aims to maintain this distribution, contingent on investment income and market conditions. Future distributions may include net investment income, realized capital gains, or return of capital. The fund managed $408 billion in assets as of September 30, 2022.
Neuberger Berman High Yield Strategies Fund (NYSE American: NHS) declared a monthly distribution of $0.0905 per share, payable on October 31, 2022. The record date is October 17, 2022 and the ex-date is October 14, 2022. The Fund aims to maintain this distribution level, influenced by income stability, leverage costs, and fees. Future distributions may include net investment income, capital gains, and return of capital. Risks involve market performance declines, economic downturns, and regulatory changes.
Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) has declared a monthly distribution of $0.0905 per share, payable on September 30, 2022. The record date is September 15, 2022, with an ex-date of September 14, 2022. This distribution is part of the Fund's level distribution policy, aiming for regular monthly distributions, contingent upon market conditions. Importantly, future distributions may include net investment income, capital gains, and returns of capital, reflecting the Fund's income stability and management fees.
Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) has declared a monthly distribution of $0.0905 per share of common stock, payable on August 31, 2022. The record date is August 15, 2022, with an ex-date of August 12, 2022. The Fund aims to maintain a stable distribution, which may include net investment income, capital gains, and return of capital. Future distributions depend on various factors, such as income stability and Fund expenses. The final determination of each distribution's source will be made at the year-end.
Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) has declared a monthly distribution of $0.0905 per share, payable on July 29, 2022. The record date is July 15, 2022 and the ex-date is July 14, 2022. The Fund aims to maintain this distribution amount, subject to market conditions, relying on income stability and expenses. Future distributions may include net investment income, capital gains, and return of capital. The Fund holds $447 billion in client assets as of March 31, 2022.
Neuberger Berman High Yield Strategies Fund (NYSE American: NHS) has announced a successful private placement of $26.5 million through a Floating Rate Senior Note, maturing in September 2023. This action increases the Fund's leverage post a recent rights offering, which raised approximately $40.9 million by issuing 4,763,981 shares. The funds will be reinvested into portfolio securities aligned with the Fund's investment objectives.
Neuberger Berman High Yield Strategies Fund Inc. (NHS) has declared a monthly distribution of $0.0905 per share, payable on June 30, 2022, with a record date of June 15, 2022 and an ex-date of June 14, 2022. Following its stable distribution policy, the Fund plans to maintain this distribution amount, contingent on market conditions and investment income stability. Future distributions may include net investment income, capital gains, or return of capital, with specific tax characteristics determined at year-end.
Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) announced the final results of its rights offering that expired on May 17, 2022. The final subscription price was set at $8.60, equal to 87% of the Fund's net asset value per share on the expiration date. A total of 4,763,981 shares will be issued, generating gross proceeds of approximately $40.9 million. Shares are expected to be issued by May 25, 2022. Investors will receive refunds for any excess payments made during the offering.
Neuberger Berman High Yield Strategies Fund (NYSE American: NHS) completed its transferable rights offering, which ran from April 19 to May 17, 2022. Each stockholder received one right per share held, requiring three rights to purchase additional shares at a final subscription price of $8.60, representing 87% of the share's net asset value. The offering is expected to result in approximately 4,811,400 shares issued and gross proceeds of $41.3 million. Final results will be announced later.